Author Archives for Adeline Chauvigné

Ipi Santé : new member

IPISANTE is developing a customized web collaborative tool, and is performing, for healthcare and wellness professionals, digital solutions which are... View Article

Rédigé par Adeline Chauvigné, le 2016-05-09

Ipi Santé : new member

IPISANTE is developing a customized web collaborative tool, and is performing, for healthcare and wellness professionals, digital solutions which are... View Article

UBO : new member

The University of Western Brittany (UBO) is focusing its activities in the marine areas, human and social sciences, health and... View Article

Rédigé par Adeline Chauvigné, le 2016-05-09

UBO : new member

The University of Western Brittany (UBO) is focusing its activities in the marine areas, human and social sciences, health and... View Article

Pierre Fabre : New member

Pierre Fabre is a private pharmaceutical and dermo-cosmetics group, founded in 1962, by Pierre Fabre. In 2015, its turnover exceeded... View Article

Rédigé par Adeline Chauvigné, le 2016-05-09

Pierre Fabre : New member

Pierre Fabre is a private pharmaceutical and dermo-cosmetics group, founded in 1962, by Pierre Fabre. In 2015, its turnover exceeded... View Article

Gene therapy, a strategic sector in the Pays de Loire region

“The CESTI IHU is a great tool to maintain and strengthen our competitiveness,” said Philippe Moullier, research director at INSERM... View Article

Rédigé par Adeline Chauvigné, le 2016-05-10

Gene therapy, a strategic sector in the Pays de Loire region

“The CESTI IHU is a great tool to maintain and strengthen our competitiveness,” said Philippe Moullier, research director at INSERM... View Article

Green light for the european BOOST4HEALTH project

On February the 25th, the European project Boost4Health successfully passed the final selection step at the North West Europe INTERREG... View Article

Murielle Cazaubiel elevated to the rank of Knight of the Legion of Honor

On March 7th, in the presence of the Prefect, Murielle Cazaubiel, manager of Biofortis Merieux Nutrisciences, received the insignia of... View Article

Join the Bioregate Forum 2016 in Nantes!

Bioregate Forum is a biannual European meeting dedicated to highlighting latest scientific, technological, clinical & commercialization approaches in the field... View Article

Effimune & Ose Pharma announce proposed merger to create significan immunotherapy player

OSE Pharma, an immuno-oncology company with a specific immunotherapy activating T lymphocytes, currently in a registration Phase 3 study, and Effimune, a... View Article

Rédigé par Adeline Chauvigné, le 2016-03-21

Effimune & Ose Pharma announce proposed merger to create significan immunotherapy player

OSE Pharma, an immuno-oncology company with a specific immunotherapy activating T lymphocytes, currently in a registration Phase 3 study, and Effimune, a... View Article

Valneva Announces $42 Million IXIARO® Supply Contract with US Government

Valneva SE (“Valneva” or “the Company”), a leading pure play vaccine company, announces today the signing of a $42 million... View Article

Rédigé par Adeline Chauvigné, le 2016-03-21

Valneva Announces $42 Million IXIARO® Supply Contract with US Government

Valneva SE (“Valneva” or “the Company”), a leading pure play vaccine company, announces today the signing of a $42 million... View Article

Effimune and In Cell Art collaborate to develop a novel therapeutic approach in immunology

PR 110216Final The two biotechnology companies in Nantes develop a novel approach aiming at the production of therapeutic antibodies directly... View Article

Rédigé par Adeline Chauvigné, le 2016-02-11

Effimune and In Cell Art collaborate to develop a novel therapeutic approach in immunology

PR 110216Final The two biotechnology companies in Nantes develop a novel approach aiming at the production of therapeutic antibodies directly... View Article